CVS Health revenue and financials
$86.43Change from previous close: −0.67%Absolute change: −$0.58
In the fiscal year ended December 2025, CVS Health reported revenue of $402.07B (+7.85% year over year). Net income was $1.77B, a net margin of 0.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +7.85%
- 2025 vs 2024
- Net income growth
- −61.68%
- 2025 vs 2024
- Net margin
- 0.4%
- 2024: 1.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10,639 | 9,107 | 13,426 | 16,177 | 18,265 | 15,865 | 12,848 | 8,865 | 8,007 | 10,141 |
| Depreciation and amortization | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 | 4,441 | 4,371 | 2,718 | 2,479 | 2,475 |
| Capital expenditure | -2,832 | -2,781 | -3,031 | -2,727 | -2,520 | -2,437 | -2,457 | -2,037 | -1,918 | -2,224 |
| Investing cash flow | -5,871 | -7,613 | -20,889 | -5,047 | -5,261 | — | — | — | — | — |
| Financing cash flow | -4,940 | -1,135 | 2,683 | -10,516 | -11,356 | — | — | — | — | — |
| Dividends paid | -3,397 | -3,373 | -3,132 | -2,907 | -2,625 | -2,624 | -2,603 | -2,038 | -2,049 | -1,840 |
| Share repurchases | 0.0 | -3,023 | -2,012 | -3,500 | 0.0 | 0.0 | 0.0 | 0.0 | -4,361 | -4,461 |
| Debt issued | 3,969 | 9,832 | 16,098 | 0.0 | 987 | — | — | — | — | — |
| Debt repaid | -5,748 | -4,773 | -8,166 | -4,211 | -10,254 | — | — | — | — | — |
| Net change in cash | -172 | 359 | -4,780 | 614 | 1,648 | — | — | — | — | — |
| Free cash flow | 7,807 | 6,326 | 10,395 | 13,450 | 15,745 | — | — | — | — | — |
| Levered free cash flow | 5,930 | 6,909 | 11,075 | 11,935 | 14,783 | — | — | — | — | — |